Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen

This study has been completed.
Information provided by (Responsible Party):
Sanofi Identifier:
First received: January 4, 2010
Last updated: May 9, 2016
Last verified: May 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: May 9, 2016